NCT07020273 CONNECT Cancer Survivors With Tobacco Treatment
| NCT ID | NCT07020273 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Tobacco Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5,000 participants in total. It began in 2025-07-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic cluster randomized trial (CRT) to test the effectiveness of nudges to change (ELEVATE-S) vs. quit-focused usual care (ELEVATE) in increasing tobacco treatment (use of medication, brief advice, or referral to external counseling) and smoking cessation.
Eligibility Criteria
Eligibility Criteria: * Be receiving care at a participating clinic * Report current tobacco use (assessed by the rooming staff during the index visit) * Have a completed appointment with a participating clinic * Be an adult (at least 18 years old).
Contact & Investigator
Li-Shiun Chen, M.D., MPH, ScD
PRINCIPAL INVESTIGATOR
Washington University School of Medicine
Frequently Asked Questions
Who can join the NCT07020273 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tobacco Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07020273 currently recruiting?
Yes, NCT07020273 is actively recruiting participants. Contact the research team at li-shiun@wustl.edu for enrollment information.
Where is the NCT07020273 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07020273 clinical trial?
NCT07020273 is sponsored by Washington University School of Medicine. The principal investigator is Li-Shiun Chen, M.D., MPH, ScD at Washington University School of Medicine. The trial plans to enroll 5,000 participants.